Cold-aggravated pain in humans caused by a hyperactive NaV1.9 channel mutant.

Authors:
Leipold E, Hanson-Kahn A, Frick M, Gong P, Bernstein JA, Voigt M, Katona I, Oliver Goral R, Altmüller J, Nürnberg P, Weis J, Hübner CA, Heinemann SH, Kurth I.
In:
Source: Nat Commun.
Publication Date: (2015)
Issue: 8(6): 1-11
Research Area:
Neurobiology
Cells used in publication:
Dorsal root ganglion (DRG), mouse
Species: mouse
Tissue Origin: brain
Platform:
4D-Nucleofector® X-Unit
Experiment
Transfection of mouse DRGs with P3 solution and program CA-137 (20µl samples) Details: Isolated DRG neurons were transfected by electroporation using a 4D-Nucleofector (Lonza, Basel, Switzerland) with the P3 Primary Cell 4D-Nucleofector X Kit S (V4XP-3032). Briefly, DRG neurons from each animal were split in two equal lots to enable experiments with wild-type and mutant NaV1.9 channels using the same batch of cells. After centrifugation (100 g for 3min) both cell pellets were resuspended individually in 20 ml of P3 primary cell solution containing supplement 1 and 0.3 mg of a plasmid encoding the enhanced green fluorescent protein. Subsequently, one lot was supplemented with 1.2 µg of a NaV1.9-encoding plasmid, while the second lot was supplemented with 1.2 µg of a vector encoding mutant NaV1.9 variants. Transfection was performed using the electroporation protocol CA137 of the 4D-Neucleofector. After electroporation, 150 ml of low calcium Roswell Park Memorial Institute (Invitrogen) 1640 medium was added to each cell suspension and cells were allowed to recover for 10 min in a 10% CO2 incubator at 37 C. The cell suspensions were then diluted in 300 ml DRG medium and immediately seeded on poly-D-lysin/laminin-coated glass coverslips, which were placed in the slots of a 24-well plate containing 1ml of DRG medium per well. DRG medium contained 89.5% DMEM/F12 (Dulbecco’s Modified Eagles Medium with Ham’s F12; Invitrogen) supplemented with 9.5% fetal calf serum and 1% penicillin/streptomycin (Invitrogen).
Abstract
Gain-of-function mutations in the human SCN11A-encoded voltage-gated Na(+) channel NaV1.9 cause severe pain disorders ranging from neuropathic pain to congenital pain insensitivity. However, the entire spectrum of the NaV1.9 diseases has yet to be defined. Applying whole-exome sequencing we here identify a missense change (p.V1184A) in NaV1.9, which leads to cold-aggravated peripheral pain in humans. Electrophysiological analysis reveals that p.V1184A shifts the voltage dependence of channel opening to hyperpolarized potentials thereby conferring gain-of-function characteristics to NaV1.9. Mutated channels diminish the resting membrane potential of mouse primary sensory neurons and cause cold-resistant hyperexcitability of nociceptors, suggesting a mechanistic basis for the temperature dependence of the pain phenotype. On the basis of direct comparison of the mutations linked to either cold-aggravated pain or pain insensitivity, we propose a model in which the physiological consequence of a mutation, that is, augmented versus absent pain, is critically dependent on the type of NaV1.9 hyperactivity.